CS
YDESW

Clear Street’s YD Bio Ltd Warrants YDESW Stock Holding History

Clear Street’s Portfolio YDESW Stock Details YDESW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.5K Buy
102,358
+8,200
+9% +$6.96K ﹤0.01% 687
2025
Q4 		$93.2K Sell
94,158
-6,872
-7% -$9.69K ﹤0.01% 516
2025
Q3 		$215K Buy
+101,030
New +$176K ﹤0.01% 347

Other funds holding YDESW

CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
TNA
True North Advisors Dallas, Texas $877M AUM 13.86% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $9.2B AUM 23.26% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return

Clear Street's YDESW Position: Q1 2026 in Review

Clear Street increased its YD Bio Ltd Warrants (YDESW) stake by 8.7% in Q1 2026, buying an estimated $6.96K and bringing the position to 102,358 shares worth $66.5K. The position accounts for ﹤0.01% of the portfolio, ranked #687.

Clear Street first reported a position in YDESW in Q3 2025 and has held it in 3 quarters since. The position peaked at $215K in Q3 2025. 9 funds tracked by Wall St. Rank hold YDESW as of Q1 2026.

  • Clear Street held 102,358 shares of YD Bio Ltd Warrants worth $66.5K as of Q1 2026.
  • Clear Street bought 8,200 YD Bio Ltd Warrants shares in Q1 2026, an estimated $6.96K.
  • YD Bio Ltd Warrants made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #687 holding.
  • Clear Street first reported a position in YD Bio Ltd Warrants in Q3 2025 and has held it in 3 quarters since.
  • Clear Street's YD Bio Ltd Warrants position peaked at $215K in Q3 2025.
  • 9 funds tracked by Wall St. Rank held YD Bio Ltd Warrants as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.